tapinarof; benvitimod, 3,5-dihydroxy-4-isopropylstilbene (VTMA)
Jump to navigation
Jump to search
Indications
- atopic dermatitis (FDA-approved age >= 2 years)[2]
- psoriasis
Dosage
- apply topically once daily
Cream 1%
Adverse effects
Mechanism of action
- aryl hydrocarbon receptor (AhR)-modulating agent
More general terms
References
- ↑ Bissonnette R, Stein Gold L, Rubenstein DS, Tallman AM, Armstrong A. Tapinarof in the treatment of psoriasis: A review of the unique mechanism of action of a novel therapeutic aryl hydrocarbon receptor-modulating agent. J Am Acad Dermatol. 2021 Apr;84(4):1059-1067 PMID: https://www.ncbi.nlm.nih.gov/pubmed/33157177 Free article
- ↑ 2.0 2.1 Ingram I Nonsteroidal Topical OK'd for Atopic Dermatitis. FDA approves tapinarof cream 1% for adults and kids 2 years and up. MedPage Today December 17, 2024 https://www.medpagetoday.com/dermatology/atopy/113428
- ↑ Highlights of Prescribing Information VTAMA (tapinarof) cream, for topical use https://www.vtama.com/hcp/PI/